Japanese multinational imaging and electronics company Ricoh has shown its commitment to developing a presence within the biomedical industry in a new agreement combining 3D bioprinting with cell differentiation technology. Acquiring a 34.5% stake in Maryland biotechnology company Elixirgen Scientific, Ricoh has created a strategic business partnership that will also see the launch of a North American […]
187 Replies to “Ricoh cements position in 3D bioprinting market with investment in Elixirgen Scientific”
Comments are closed.